Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

David R Langley

2PUBLICATIONS

30CO-AUTHORS

Molecular targetsGene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|May 31, 2024

Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models.

Sheryl M Gough, John J Flanagan, Jessica Teh

|Jan 19, 2022

PROTAC targeted protein degraders: the past is prologue.

Miklós Békés, David R Langley, Craig M Crews

Pageof 1

Frequent Collaborators

2 joint publications

Miklós Békés

1 joint publications

Craig M Crews

1 joint publications

Sheryl M Gough

1 joint publications

John J Flanagan

1 joint publications

Jessica Teh

1 joint publications

Monica Andreoli

1 joint publications

Emma Rousseau

1 joint publications

Melissa Pannone

1 joint publications

Mark Bookbinder

1 joint publications

Ryan Willard

Frequent Collaborators

2 joint publications

Miklós Békés

1 joint publications

Craig M Crews

1 joint publications

Sheryl M Gough

1 joint publications

John J Flanagan

Top Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on : Aug 13, 2019

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on : Nov 09, 2020

See more related videos

Top Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on : Aug 13, 2019

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on : Nov 09, 2020

See more related videos